The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
While “U.S. exceptionalism” has undoubtedly helped drive Wall Street’s record-busting returns in recent years, it should not be confused with isolationism.The fourth-quarter U.S. earnings season that ...